Valuation (12%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -22.76 | -16.67 |
| PEG Ratio (TTM) | -0.81 | -5.49 |
| P/S Ratio (TTM) | 87.10 | 37.47 |
| P/B Ratio (TTM) | 2.34 | 5.86 |
| P/FCF Ratio (TTM) | -197.53 | -148.99 |
| Price to 5YR AVG Earnings Ratio | N/A | -33.81 |
| Price to 5YR AVG FCF Ratio | N/A | -1.26 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -5.49% | 284.65% |
| ROE (TTM) | -9.25% | -4,181.05% |
| Net Profit Margin (TTM) | -212.35% | -1,000.23% |
| ROIC 5YR AVG | N/A | -16.06% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -655.30% | 83,328.33% | N/A |
| Revenue | -25.00% | N/A | N/A |
| Net Income | -618.17% | 120,229.90% | N/A |
| Cash Flow | -236.53% | -88,198.65% | N/A |
Health (12%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.00 | 4.92 |
| Quick Ratio (TTM) | 0.00 | 4.89 |
| D/E Ratio (TTM) | N/A | 1.28 |
| Interest Coverage (TTM) | N/A | -11.13 |
| Piotroski F-Score | 3 | 3 |
| Altman Z-Score | 1.78 | 20.79 |
| LTL to 5YR AVG FCF | N/A | -0.53 |
| Shares Outstanding Growth 5YR AVG | N/A | 887.85% |